Latest Production News

Bastion Mining has taken control of over 90% of Xanadu Mines shares through a takeover bid, moving swiftly to compulsory acquisition and setting the stage for the Kharmagtai project’s next phase.

Paradigm Biopharmaceuticals has advanced its global Phase 3 trial for knee osteoarthritis pain with active patient recruitment in Australia and the US, backed by a $41.2 million convertible note facility. The company also expanded its osteoarthritis portfolio through the acquisition of Proteobioactives and the Pentacoxib™ oral therapy.

OpenLearning Limited reported a robust Q2 FY25 with 22% year-on-year SaaS ARR growth to $2.65 million, driven by significant multi-year contract wins and expanding global customer base. The company’s AI-powered LMS strategy is delivering larger deals and improved cash flow metrics.

Andean Silver Limited reports a significant 22% increase in silver equivalent ounces at its Cerro Bayo project, alongside progress on a production restart study and a successful A$30 million capital raise.

QPM Energy has successfully completed major commissioning runs at its Townsville Power Station, generating over 4,700 MWh and preparing to take operational control. Final steps are underway to leverage new gas agreements and electricity market opportunities.

Bannerman Energy reports robust progress on its Etango Uranium Project, achieving key construction milestones and securing A$85 million in fresh equity to fuel its path to a Final Investment Decision.

Brazilian Rare Earths Limited (BRE) confirms Sulista West as an ultra high-grade rare earth project with exceptional drill results and reports metallurgical breakthroughs at Monte Alto, underpinning its integrated supply chain ambitions.

Bannerman Energy reported a robust $80 million cash inflow from financing in Q2 2025, offsetting significant exploration expenditures and maintaining a strong cash position.

Cavalier Resources progresses its Crawford Gold Project with key milestones including an $11 million stream finance negotiation with Raptor Capital and the appointment of Colin Bald as General Manager of Operations.

SomnoMed reports a robust Q4 FY25 with 25% revenue growth and a milestone of treating over 1 million patients, while gearing up for significant capacity expansion and clinical advancements.

Avecho Biotechnology reports strong progress in its Phase III clinical trial for a CBD-based insomnia treatment, with recruitment accelerating across multiple Australian sites and interim results expected early next year.

Arafura Rare Earths pushes forward with equity funding for its Nolans Project, targeting a €100 million investment from Germany’s Raw Materials Fund amid rising geopolitical tensions reshaping the rare earths landscape.